Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
liothyronine (cytomel) (2 trials)
repaglinide (prandin) (1 trial)
sitagliptin (januvia) (1 trial)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Trials (3 total)
Trial APIs (3 total)